Total Funding
$149.1M
Employee Range
101-250
Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):
Promethera Biosciences data powered by:
Share
Promethera Biosciences data powered by:
Promethera BiosciencesOverall Ranking
City Rank
Share
Loading...
In Mont-Saint-Guibert
Top null%out of startups
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
Promethera BiosciencesIndustry Rankings in
HealthtechCity Rank
Share
2nd
In Mont-Saint-Guibert
Top 40%out of 5 startups
National Rank
Share
14th
In Belgium
Top 13%out of 112 startups
Regional Rank
Share
482nd
In Western Europe
Top 11%out of 4549 startups
Promethera BiosciencesSubindustry Rankings in
BiotechnologyCity Rank
Share
2nd
In Mont-Saint-Guibert
Top 50%out of 4 startups
National Rank
Share
10th
In Belgium
Top 18%out of 57 startups
Regional Rank
Share
163rd
In Western Europe
Top 10%out of 1726 startups
rankings by:
Promethera BiosciencesSB Rank Evolution
Not enough data points to display the chart.
Promethera BiosciencesstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro